In addition, studies have shown that patients with cancer are at greater risk of being infected by SARS-CoV-2 (Wang et al., 2021), considering the functions of TMPRSS2 in the COVID-19 infection, medicating the cancer patients infected COVID-19 requires thoughtful consideration. This evidence concerns the gene TMPRSS2 and cancer.